Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial

Author:

Keller Michael B.123,Tian Xin4,Jang Moon Kyoo12,Meda Rohan2,Charya Ananth5,Berry Gerald J.16,Marboe Charles C.17,Kong Hyesik12,Ponor Ileana L.8,Aryal Shambhu19,Orens Jonathan B.13,Shah Pali D.13,Nathan Steven D.19,Agbor-Enoh Sean123ORCID

Affiliation:

1. Genomic Research Alliance for Transplantation, Bethesda, Maryland;

2. Laboratory of Applied Precision Omics and

3. Division of Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland;

4. Office of Biostatistics Research, NHLBI, NIH, Bethesda, Maryland;

5. University of Maryland Medical Center, Baltimore, Maryland;

6. School of Medicine, Stanford University, Stanford, California;

7. Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons of Columbia University, New York, New York;

8. Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland; and

9. Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Fairfax, Virginia

Funder

Cystic Fibrosis Foundation

NIH Distinguished Scholar Program

National Heart, Lung, and Blood Institute Division of Intramural Research

Publisher

American Thoracic Society

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3